The article, Safety of Kidney Transplantation from Donors with HIV, details findings supporting HIV-to-HIV kidney transplants as safe and just as effective as those using organs from donors without ...

Gilead Sciences, Inc. (Nasdaq: GILD) today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE ...

Gilead (GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention treatment lenacapavir ...

The Ochsner Transplant Institute served as one of 26 U.S. transplant centers collaborating in an HIV-to-HIV kidney transplant study ...

The supply of health care professionals available to provide HIV care continues to decline, even as the need for HIV care and ...

The supply of health care professionals available to provide HIV care is expected to continue to decline over the next ...

NIH-funded research offers evidence on transplantation practices that are currently confined to research environments. A ...

A recent study reveals that nearly 20% of United States physicians treating HIV patients plan to leave or reduce their ...

Revolutionary new HIV drugs are being made available in 120 low-income countries, but many important populations are being left out. Sophie Cousins reports.

Sciences presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial, which is studying ...

According to findings from a multicenter study led by Johns Hopkins Medicine and released today in The New England Journal of ...